These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

962 related articles for article (PubMed ID: 19252486)

  • 1. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism.
    Andriopoulos B; Corradini E; Xia Y; Faasse SA; Chen S; Grgurevic L; Knutson MD; Pietrangelo A; Vukicevic S; Lin HY; Babitt JL
    Nat Genet; 2009 Apr; 41(4):482-7. PubMed ID: 19252486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.
    Ramos E; Kautz L; Rodriguez R; Hansen M; Gabayan V; Ginzburg Y; Roth MP; Nemeth E; Ganz T
    Hepatology; 2011 Apr; 53(4):1333-41. PubMed ID: 21480335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo.
    Zhang AS; Gao J; Koeberl DD; Enns CA
    J Biol Chem; 2010 May; 285(22):16416-23. PubMed ID: 20363739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression.
    Nili M; Shinde U; Rotwein P
    J Biol Chem; 2010 Aug; 285(32):24783-92. PubMed ID: 20530805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.
    Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H
    Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling.
    Fillebeen C; Wilkinson N; Charlebois E; Katsarou A; Wagner J; Pantopoulos K
    Blood; 2018 Oct; 132(17):1829-1841. PubMed ID: 30213871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6.
    Canali S; Wang CY; Zumbrennen-Bullough KB; Bayer A; Babitt JL
    Am J Hematol; 2017 Nov; 92(11):1204-1213. PubMed ID: 28815688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis.
    Corradini E; Garuti C; Montosi G; Ventura P; Andriopoulos B; Lin HY; Pietrangelo A; Babitt JL
    Gastroenterology; 2009 Oct; 137(4):1489-97. PubMed ID: 19591830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo.
    Arndt S; Maegdefrau U; Dorn C; Schardt K; Hellerbrand C; Bosserhoff AK
    Gastroenterology; 2010 Jan; 138(1):372-82. PubMed ID: 19786029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?
    Rausa M; Pagani A; Nai A; Campanella A; Gilberti ME; Apostoli P; Camaschella C; Silvestri L
    PLoS One; 2015; 10(4):e0122696. PubMed ID: 25860887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice.
    Canali S; Zumbrennen-Bullough KB; Core AB; Wang CY; Nairz M; Bouley R; Swirski FK; Babitt JL
    Blood; 2017 Jan; 129(4):405-414. PubMed ID: 27864295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemojuvelin is essential for transferrin-dependent and transferrin-independent hepcidin expression in mice.
    Bartnikas TB; Fleming MD
    Haematologica; 2012 Feb; 97(2):189-92. PubMed ID: 21993681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional disruption of mouse HFE2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin.
    Gkouvatsos K; Wagner J; Papanikolaou G; Sebastiani G; Pantopoulos K
    Hepatology; 2011 Nov; 54(5):1800-7. PubMed ID: 21748766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis.
    Lee DH; Zhou LJ; Zhou Z; Xie JX; Jung JU; Liu Y; Xi CX; Mei L; Xiong WC
    Blood; 2010 Apr; 115(15):3136-45. PubMed ID: 20065295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.
    Babitt JL; Huang FW; Wrighting DM; Xia Y; Sidis Y; Samad TA; Campagna JA; Chung RT; Schneyer AL; Woolf CJ; Andrews NC; Lin HY
    Nat Genet; 2006 May; 38(5):531-9. PubMed ID: 16604073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans.
    Daher R; Kannengiesser C; Houamel D; Lefebvre T; Bardou-Jacquet E; Ducrot N; de Kerguenec C; Jouanolle AM; Robreau AM; Oudin C; Le Gac G; Moulouel B; Loustaud-Ratti V; Bedossa P; Valla D; Gouya L; Beaumont C; Brissot P; Puy H; Karim Z; Tchernitchko D
    Gastroenterology; 2016 Mar; 150(3):672-683.e4. PubMed ID: 26582087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge.
    Latour C; Besson-Fournier C; Gourbeyre O; Meynard D; Roth MP; Coppin H
    Blood; 2017 Nov; 130(21):2339-2343. PubMed ID: 29021231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis.
    Silvestri L; Pagani A; Camaschella C
    Blood; 2008 Jan; 111(2):924-31. PubMed ID: 17938254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice.
    Corradini E; Schmidt PJ; Meynard D; Garuti C; Montosi G; Chen S; Vukicevic S; Pietrangelo A; Lin HY; Babitt JL
    Gastroenterology; 2010 Nov; 139(5):1721-9. PubMed ID: 20682319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease.
    Wang L; Trebicka E; Fu Y; Ellenbogen S; Hong CC; Babitt JL; Lin HY; Cherayil BJ
    Inflamm Bowel Dis; 2012 Jan; 18(1):112-9. PubMed ID: 21351217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.